Valuation: Bayer AG

Market Cap 49.81B 56.94B 45.93B 42.5B 80.66B 5,435B 82.01B 550B 216B 2,669B 214B 209B 9,245B P/E 2026 *
21.8x
P/E 2027 * 16.4x
Enterprise Value 81.54B 93.22B 75.2B 69.58B 132B 8,898B 134B 901B 353B 4,369B 350B 342B 15,135B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.68x
Free-Float
100%
Yield 2026 *
0.45%
Yield 2027 * 1.24%
1 day-1.01%
1 week-2.84%
Current month+6.63%
1 month+45.90%
3 months+27.78%
6 months+31.39%
Current year+40.64%
1 week 49.36
Extreme 49.36
54
1 month 35.44
Extreme 35.44
54
Current year 32.97
Extreme 32.971
54
1 year 24.82
Extreme 24.815
54
3 years 18.37
Extreme 18.368
54
5 years 18.37
Extreme 18.368
67.99
10 years 18.37
Extreme 18.368
123.77
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 66 2022-03-31
Director/Board Member 60 2017-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-2.84% - - 56.94B
-2.45%-1.09%+50.13%+161.94% 1,085B
-0.37%-0.39%+63.81%+61.94% 624B
-1.31%-3.27%+26.37%+83.23% 442B
-0.92%-1.41%+27.68%+26.60% 332B
-3.29%-11.00%+21.08%+26.39% 277B
-0.07%-2.89%+25.21%+44.81% 282B
+0.66%-1.42%-29.26%-39.30% 217B
+0.03%-0.85%+20.96%+61.67% 196B
-2.57%+1.45%+14.80%+73.72% 167B
Average -1.15%-1.86%+24.53%+55.67% 402.44B
Weighted average by Cap. -1.40%-1.06%+35.40%+81.68%

Financials

2026 *2027 *
Net sales 45.57B 52.1B 42.03B 38.89B 73.81B 4,973B 75.04B 503B 197B 2,442B 196B 191B 8,458B 46.7B 53.39B 43.07B 39.85B 75.64B 5,096B 76.9B 516B 202B 2,502B 200B 196B 8,668B
Net income 2.11B 2.41B 1.95B 1.8B 3.42B 230B 3.48B 23.33B 9.14B 113B 9.06B 8.87B 392B 2.93B 3.35B 2.7B 2.5B 4.74B 320B 4.82B 32.34B 12.68B 157B 12.57B 12.3B 544B
Net Debt 31.74B 36.28B 29.27B 27.08B 51.4B 3,463B 52.25B 350B 137B 1,700B 136B 133B 5,890B 28.53B 32.61B 26.31B 24.34B 46.2B 3,113B 46.97B 315B 123B 1,528B 122B 120B 5,294B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-07-10 51.62 +1.89% 525
26-07-09 €50.45 +1.06% 1,296,362
26-07-08 €49.92 -2.65% 1,388,868
26-07-07 €51.28 -0.96% 822,131
26-07-06 €51.77 -2.55% 3,692,990
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
50.70EUR
Average target price
54.62EUR
Spread / Average Target
+7.73%

Quarterly revenue - Rate of surprise